An2 Therapeutics, Inc. · NASDAQ:ANTX
Marks Gilbert Lynn received 2,789 An2 Therapeutics, Inc. shares as an award (Form 4)
Traded Jul 10, 2026 · Filed Jul 10, 2026
On Jul 10, 2026, Marks Gilbert Lynn (Director) received 2,789 An2 Therapeutics, Inc. shares as an award, leaving 81,873 shares. Filed Jul 10, 2026 (Form 4).
- Awarded
- 2,789 shares
- Holding after
- 81,873 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 10, 2026 | Common Stock | Award | 2,789 | 81,873 | Direct |
Source
Related
- An2 Therapeutics, Inc.
- Marks Gilbert Lynn
- An2 Therapeutics, Inc. shareholders
- Form 4 · Marks Gilbert Lynn · Oct 13, 2026
- Form 4 · Marks Gilbert Lynn · Apr 10, 2026
- Form 4 · Aziz Kabeer · Oct 13, 2026
- Form 4 · Martin Patricia A. · Oct 13, 2026
- Form 4 · Trenor Cameron C. III · Sep 16, 2026
- Form 4 · Readnour Robin Shane · Sep 11, 2026
- Form 4 · Readnour Robin Shane · Sep 8, 2026